"Provide Individualized Retina and Uveitis Care to Greater Capital Region"

During the past decade, The Retina Consultants conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Retina Consultants" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Jaeb Center for Health Research" with 2 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored, "EyePoint Pharmaceuticals, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Retina Consultants" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Office of Dietary Supplements (ODS)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "The Retina Consultants" are "Diabetic Macular Edema" (4 trials), "Diabetic Retinopathy" (2 trials), "Age-related Macular Degeneration" (1 trials), "Cataract" (1 trials) and "Choroidal Neovascularization" (1 trials). Many other conditions were trialed in "The Retina Consultants" in a lesser frequency.

Most popular intervention types in "The Retina Consultants" are "Drug" (11 trials), "Procedure" (3 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (6 trials), "Faricimab" (5 trials), "Aflibercept" (2 trials), "1mg triamcinolone acetonide" (1 trials) and "4mg CLS-TA Suprachoriodal Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Retina Consultants" are 12 trials for "All" genders.

Currently, there are NaN active trials in "The Retina Consultants". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in The Retina Consultants, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Retina Consultants, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".